COLLEEN MITCHELL: Open Payments
NPI 1235119546 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,769 in 162 payments from 17 companies in 2025. Trend: 2023 $1,706 · 2024 $2,878 · 2025 $2,769
Food & beverage: $2,669Education: $100
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 28 | $632 |
| ABBVIE INC. | 39 | $553 |
| Janssen Biotech, Inc. | 21 | $397 |
| LEO Pharma Inc. | 10 | $205 |
| Amgen Inc. | 13 | $167 |
| UCB, Inc. | 10 | $147 |
| Novartis Pharmaceuticals Corporation | 10 | $143 |
| Lilly USA, LLC | 13 | $136 |
| Regeneron Healthcare Solutions, Inc. | 5 | $117 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $57 |
Products named: Sotyktu, TREMFYA, SKYRIZI, RINVOQ, DUPIXENT, OTEZLA, Bimzelx, TALTZ.
Industry payments across KS — which companies pay providers there.
